Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Finasteride effectively treats male hair loss, improving growth and density.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

The study created a new method to test drugs that affect hormone processing in skin.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

DHT affects testicular development and regulates spermatogenesis in some fish.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

MK-386 lowers DHT in blood and skin but not in semen.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Finasteride may cause kidney damage.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.